Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Vaccine

• Publication date

  2001-10-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(01)00323-1PMID 11567745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Feline Immunodeficiency Virus Clade C Mucosal Transmission and Disease Courses

  2000cited by this paper
• Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge.

  2000cited by this paper
• A rational basis for mucosal vaccination against HIV infection

  1999cited by this paper
• Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women

  1999cited by this paper
• AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus.

  1999cited by this paper
• Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes.

  1999cited by this paper
• Mucosal infection and vaccination against feline immunodeficiency virus.

  1999cited by this paper
• Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques.

  1998cited by this paper
• Determination of salivary and serum immunoglobulin concentrations in the cat.

  1998cited by this paper
• Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted

  1997cited by this paper
• FIV infection of the domestic cat: an animal model for AIDS.

  1997cited by this paper
• Mucosal Transmission of Cell-Associated and Cell-Free Feline Immunodeficiency Virus

  1997cited by this paper
• Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.

  1996cited by this paper
• Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

  1996cited by this paper
• Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection

  1996cited by this paper
• Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response.

  1996cited by this paper
• Vaginal and rectal infection of cats with feline immunodeficiency virus.

  1996cited by this paper
• Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus

  1995cited by this paper
• Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen

  1995cited by this paper
• Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines

  1995cited by this paper
• Detection of feline immunodeficiency virus in semen from seropositive domestic cats (Felis catus)

  1995cited by this paper
• Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates.

  1994cited by this paper
• Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction

  1993cited by this paper
• Specific and non-specific immunity and protection of macaques against SIV infection.

  1992cited by this paper
• Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein.

  1992cited by this paper
• Experimental Vaccine Protection Against Feline Immunodeficiency Virus

  1991cited by this paper
• Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland.

  1991cited by this paper
• Anti-cell antibody in macaques

  1991cited by this paper
• Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine

  1990cited by this paper
• Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

  1987cited by this paper

• Major Histocompatibility Complex Class I (FLA-E*01801) Molecular Structure in Domestic Cats Demonstrates Species-Specific Characteristics in Presenting Viral Antigen Peptides

  2017cites this paper
• Intralymphatic immunotherapy

  2015cites this paper
• Parenteral Vaccine Administration: Tried and True

  2015cites this paper
• Allergen immunotherapy: routes, safety, efficacy, and mode of action

  2013cites this paper
• Gene Vaccines

  2012cites this paper
• Induction of mucosal and systemic antibody and T-cell responses following prime–boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations

  2011cites this paper
• Novel administration routes for allergen-specific immunotherapy: a review of intralymphatic and epicutaneous allergen-specific immunotherapy.

  2011cites this paper
• Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea Pigs

  2011cites this paper
• Intralymphatic immunotherapy: from the rationale to human applications.

  2011cites this paper
• Vaccines Against Retrovirus: Models and Chalenges in Development of a Vaccine Against HIV

  2009cites this paper
• Intralymphatic immunotherapy

  2009cites this paper
• Alloimmunity does not protect from challenge with the feline immunodeficiency virus.

  2008cites this paper
• Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

  2008cites this paper
• FIV vaccine development: a continuing challenge

  2008cites this paper
• Vaccination against the feline immunodeficiency virus: the road not taken.

  2008cites this paper
• Mucosal challenge with cell‐associated or cell‐free feline immunodeficiency virus induces rapid and distinctly different patterns of phenotypic change in the mucosal and systemic immune systems

  2007cites this paper
• In vivo Models of HIV Disease and Control

  2006cites this paper
• FIV as a Model for HIV: An Overview

  2006cites this paper
• Mucosal defence along the gastrointestinal tract of cats and dogs.

  2006cites this paper
• FIV as a Model for AIDS Vaccine Studies

  2006influential citation
• Mucosal Infection and Immune Responses to Simian Immunodeficiency Virus

  2005cites this paper
• Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats.

  2004cites this paper
• Fc Receptor Targeting With Recombinant Immunoglobulins and Immunoglobulin Formulations

  2004cites this paper
• Mucosal immunity

  2004cites this paper
• Feline immunodeficiency virus: a concise review.

  2004cites this paper
• T cell subpopulations mediating inhibition of feline immunodeficiency virus replication in mucosally infected cats.

  2004cites this paper
• Innate and adaptive mucosal immunity in protection against HIV infection.

  2003cites this paper
• Prime-Boost Immunization Schedules Based on Influenza Virus and Vaccinia Virus Vectors Potentiate Cellular Immune Responses against Human Immunodeficiency Virus Env Protein Systemically and in the Genitorectal Draining Lymph Nodes

  2003cites this paper
• AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Protection from an Intraclade Challenge Administered Systemically or Mucosally by an Attenuated Vaccine

  2003cites this paper
• Mucosal immunity and vaccination against HIV

  2002cites this paper
• AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Failure To Protect and Possible Enhancement of Challenge Infection by Four Cell-Based Vaccines Prepared with Autologous Lymphoblasts

  2002cites this paper
• Recent advances in mucosal vaccines and adjuvants.

  2002cites this paper
• Introduction: A welcome to the first special animal health issue of AAPS PharmSci

  2002cites this paper
• FIV vaccine development and its importance to veterinary and human medicine: a review

  2002cites this paper
• Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats.

  2002cites this paper
• Feline Immunodeficiency Virus Clade C Mucosal Transmission and Disease Courses

  2000cites this paper